What AI Can Do for IVF
By Carol Lynn Curchoe and Charles L. Bormann,
Scientific American
| 01. 10. 2018
Infertility treatment is an emotional and financial rollercoaster. For couples trying to conceive (“TTC” in the many on-line support forums), repeated failure of implantation, defined as three or more failed in vitro fertilization (IVF) cycles where no clear cause can be identified, is a frequent, heartbreaking end point when the emotional, physical or financial burden of treatment becomes too high to keep looking for an answer. By some estimates, up to two thirds of patients experience failed cycles.
That means there’s a lot of opportunity to improve in a field where every small advance in technology represents a chance to make a family. A new infertility-related artificial intelligence (AI) startup thinks it can do just that—and some of the biggest players in computing are betting big that they are right.
AI is already being used to try and solve some big health care challenges. For example, IBM has developed a computational model that predicts heart failure, and has lent use of the Watson supercomputer to Memorial Sloan Kettering Cancer Center in New York to develop cancer-diagnosis and selection-of-treatment plans. Referred...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...